Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07164833 |
| Consolidated Lead Sponsor | Bilix Co |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 50 participants (ESTIMATED) |
| Registered Start Date | 2025-08-26 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Seoul National University Bundang Hospital | Seongnam, South Korea | Open Hospital Dossier -> |
| Korea University Anam Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Seoul National University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Severance Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.